Skip to main content Skip to section navigation Skip to footer
French

Acasti Pharma Inc.

  • English
  • About Us
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Clinical Pipeline
    • GTX-104
    • GTX-102
    • GTX-101
  • Investor Relations
    • Overview
    • News / Events
    • Company Info
    • Financial Results
    • Stock Data
    • Regulatory Filings
    • Governance
  • Newsroom
  • Careers
  • Contact
  • French

Media

Investor Relations

Investor Relations

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Media
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Contacts
    • FAQ
  • Financial Results
  • Stock Data
    • NASDAQ: ACST
    • Analyst Coverage
  • Regulatory Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Section 16 Filings
    • SEDAR
    • Tax Notifications
  • Governance
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News / Events

  • Overview
  • Press Releases
  • Media
  • IR Calendar
  • Email Alerts

Acasti Pharma Inc. Discusses Clinical Progress of Lead Assets and 2022 Catalysts with The Stock Day Podcast

Sep 21, 2022

Acasti Pharma transitions to orphan diseases from cardiovascular

Oct 12, 2021

Acasti Pharma outlines key benefits of recent Grace Therapeutics acquisition

Oct 8, 2021

Acasti Pharma receives funding from the Government of Canada to expand production capacity. Here’s the Proactive interview by Dr. Pierre Lemieux, PhD, Chief Operating & Scientific Officer & Co-Founder of Acasti Pharma.

Sep 9, 2019

Acasti Pharma gets new Chinese patent that paves the way for its heart disease therapy

Jun 26, 2019

MWS Interview with Acasti Pharma

Jun 14, 2019

Acasti Pharma eyes phase III success with double data readout towards year-end

Jun 4, 2019

Acasti Pharma granted allowance for patents in 3 more countries for drug candidate Capre

May 16, 2019

Acasti Pharma expects top-line results on heart disease therapy by year's end

May 6, 2019
rss_feed News RSS
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
© 2023 Acasti Pharma Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap